- Home
- About Us
Who We Are

Our Vision

Our MISSION
Formulating Hope: The Journey of a Life-Saving Molecule
Imagine a molecule – small, invisible to the naked eye, yet carrying the power to save lives. It could be insulin for someone struggling with diabetes. Or a monoclonal antibody offering hope in the fight against cancer. Or a vaccine, protecting entire communities from deadly outbreaks.
But this molecule didn’t just appear overnight. Its journey began years ago, in a lab filled with ambition and uncertainty. Some of the world’s brightest scientists and healthcare experts poured their time, intellect, and passion into its discovery. Out of millions of possibilities, this one molecule showed promise. It survived rounds of experiments, peer reviews, sleepless nights, failed attempts—and still, it held on. At last, it proved it could do something extraordinary: it could heal. But this is only the beginning.
Before this molecule could reach a patient – and truly care for someone – it needed to be cared for itself, a short but indispensable step in the life journey is called formulation. Think of formulation as “building a nest”. Like a mother’s embrace, formulation protects the molecule from the harsh realities of the outside world – extreme temperatures, light, movement, time. It ensures the molecule stays stable, effective, and ready to work, whether it’s traveling thousands of miles from a manufacturing site or navigating the complexities of the human body. Without the right formulation, even the most miraculous molecule can falter. It may lose its potency. It may become too fragile to transport. It may demand refrigeration, difficult storage, or painful delivery methods – barriers that ultimately mean fewer patients benefit from its potential.
Lamark was founded to give these molecules the care they need. Through the science of formulation, advanced analytics, and smart innovation, we build technologies that make biologics stronger, more stable, and easier to deliver. Eye drops, long-acting injectables, thermostable biosimilars – these are just some of the ways we help life-saving molecules fulfill their promise of Healthcare.
Our work spans diabetes, ophthalmology, and oncology. We collaborate with global teams and public institutions for one mission: To care for medicines – so they can care for us.
Vaibhav Bhatia
founder / ceo

Our Journey
2018
Lamark Biotech Pvt. Ltd.
is established
2019
Patent - Thermostable protein
formulation technology
2022
Exclusive In-license of a Novel Molecule from Vision Institute, France

2019
Patent - Thermostable protein
formulation technology
2023-2024
Patent - Novel Insulin formulation
Patent - A novel hydrogel
Our Focus


Accessibility

Our Culture
- Collaborative and global team of scientists and researchers
- High quality research and publications


- Driven by innovation and interdisciplinary expertise
- Solution-oriented and data-driven approach
- Strong commitment to meaningful change and long-term sustainability
- United by a common mission to tackle complex healthcare challenges with global collaboration and a focus on societal impact

our team
Global Minds, Unified Mission

Vaibhav Bhatia (Ph.D.)
CEO

Luis A D Cienfuegos (Ph.D.)
Director R&D

Jose A. Gavira (Ph.D.)
CSO
our global presence

OUR ASSOCIATES
As a B2B company, we are forging alliances with pharmaceutical companies for API manufacturing, clinical trials, and market expansion. Together, we aim to make our flagship product – Instrong, a refrigeration-independent insulin, available in every pharmacy worldwide by 2030.








